XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Balance at beginning of period (in shares) at Jan. 28, 2023   524,160,209      
Balance at beginning of period at Jan. 28, 2023 $ 938,019 $ 30 $ 2,107,013 $ (652) $ (1,168,372)
Stockholders' Equity (Deficit)          
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)   9,245,415      
Issuance of common stock for vesting of restricted stock units (“RSUs”) 1 $ 1      
Issuance of common stock in connection with equity compensation plans (in shares)   1,511,773      
Issuance of common stock in connection with equity compensation plans 13,126   13,126    
Vesting of early exercised stock options 25   25    
Stock-based compensation expense 113,369   113,369    
Other comprehensive income (loss) (349)     (349)  
Net loss (127,824)       (127,824)
Balance at end of period (in shares) at Jul. 29, 2023   534,917,397      
Balance at end of period at Jul. 29, 2023 936,367 $ 31 2,233,533 (1,001) (1,296,196)
Balance at beginning of period (in shares) at Apr. 29, 2023   528,511,394      
Balance at beginning of period at Apr. 29, 2023 922,595 $ 30 2,160,399 (1,606) (1,236,228)
Stockholders' Equity (Deficit)          
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)   5,130,041      
Issuance of common stock for vesting of restricted stock units (“RSUs”) 1 $ 1      
Issuance of common stock in connection with equity compensation plans (in shares)   1,275,962      
Issuance of common stock in connection with equity compensation plans 13,011   13,011    
Stock-based compensation expense 60,123   60,123    
Other comprehensive income (loss) 605     605  
Net loss (59,968)       (59,968)
Balance at end of period (in shares) at Jul. 29, 2023   534,917,397      
Balance at end of period at Jul. 29, 2023 936,367 $ 31 2,233,533 (1,001) (1,296,196)
Balance at beginning of period (in shares) at Feb. 03, 2024   545,973,529      
Balance at beginning of period at Feb. 03, 2024 915,147 $ 32 2,368,597 1,616 (1,455,098)
Stockholders' Equity (Deficit)          
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)   9,460,162      
Issuance of common stock for vesting of restricted stock units (“RSUs”) 1 $ 1      
Issuance of common stock in connection with equity compensation plans (in shares)   927,513      
Issuance of common stock in connection with equity compensation plans 16,923   16,923    
Stock-based compensation expense 138,522   138,522    
Other comprehensive income (loss) (11)     (11)  
Net loss (105,899)       (105,899)
Balance at end of period (in shares) at Aug. 03, 2024   556,361,204      
Balance at end of period at Aug. 03, 2024 964,683 $ 33 2,524,042 1,605 (1,560,997)
Balance at beginning of period (in shares) at May. 04, 2024   550,805,158      
Balance at beginning of period at May. 04, 2024 923,888 $ 33 2,435,213 29 (1,511,387)
Stockholders' Equity (Deficit)          
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)   4,928,832      
Issuance of common stock for vesting of restricted stock units (“RSUs”) 0        
Issuance of common stock in connection with equity compensation plans (in shares)   627,214      
Issuance of common stock in connection with equity compensation plans 16,115   16,115    
Stock-based compensation expense 72,714   72,714    
Other comprehensive income (loss) 1,576     1,576  
Net loss (49,610)       (49,610)
Balance at end of period (in shares) at Aug. 03, 2024   556,361,204      
Balance at end of period at Aug. 03, 2024 $ 964,683 $ 33 $ 2,524,042 $ 1,605 $ (1,560,997)